カテゴリー： LP Information, 世界, 医療/バイオ

血糖測定器（BGM）のグローバル市場予測2023-2029

◆英語タイトル：Global Blood Glucose Monitoring (BGM) Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23MY4210）◆商品コード：LP23MY4210
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月（※2025年版があります。お問い合わせください。）
◆ページ数：104
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「血糖測定器（BGM）のグローバル市場」は、過去の販売実績から2022年の世界の血糖測定器（BGM）の総販売量を検討し、2023年から2029年の予測される血糖測定器（BGM）の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の血糖測定器（BGM）の市場規模を掲載し、XXX百万米ドル規模の世界の血糖測定器（BGM）市場の詳細な分析を提供します。本インサイトレポートは、世界の血糖測定器（BGM）業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の血糖測定器（BGM）市場における各社の独自のポジションをより深く理解するために、血糖測定器（BGM）製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の血糖測定器（BGM）市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。血糖測定器（BGM）の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。血糖測定器（BGM）の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。血糖測定器（BGM）のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

血糖測定器（BGM）の世界主要メーカーとしては、Becton、 Dickinson and Co.、 Terumo Corporation、 Acon Laboratories Inc.、 Roche Diagnostics Ltd.、 Johnson & Johnson、 ARKRAY Inc.、 Novo Nordisk A/S、 Medtronic、 Abbott Laboratories、 Bayer AG、 Ypsomed AG、 Sanofiなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の血糖測定器（BGM）市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では血糖測定器（BGM）市場をセグメンテーションし、種類別 (血糖測定器、持続血糖測定装置、ランセット、血糖検査ストリップ)、用途別 (病院用、診療所用、家庭用、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：血糖測定器、持続血糖測定装置、ランセット、血糖検査ストリップ

・用途別区分：病院用、診療所用、家庭用、その他

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の血糖測定器（BGM）市場の10年間の市場状況・展望は？
・世界および地域別に見た血糖測定器（BGM）市場成長の要因は何か？
・血糖測定器（BGM）の市場機会はエンドマーケットの規模によってどのように変化するのか？
・血糖測定器（BGM）のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：血糖測定器（BGM）の年間販売量2018-2029、地域別現状・将来分析
・血糖測定器（BGM）の種類別セグメント：血糖測定器、持続血糖測定装置、ランセット、血糖検査ストリップ
・血糖測定器（BGM）の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・血糖測定器（BGM）の用途別セグメント：病院用、診療所用、家庭用、その他
・血糖測定器（BGM）の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の血糖測定器（BGM）市場
・企業別のグローバル血糖測定器（BGM）市場データ：2018-2023年の年間販売量、市場シェア
・企業別の血糖測定器（BGM）の年間売上：2018-2023年の売上、市場シェア
・企業別の血糖測定器（BGM）販売価格
・主要企業の血糖測定器（BGM）生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

血糖測定器（BGM）の地域別レビュー
・地域別の血糖測定器（BGM）市場規模2018-2023：年間販売量、売上
・主要国別の血糖測定器（BGM）市場規模2018-2023：年間販売量、売上
・南北アメリカの血糖測定器（BGM）販売の成長
・アジア太平洋の血糖測定器（BGM）販売の成長
・ヨーロッパの血糖測定器（BGM）販売の成長
・中東・アフリカの血糖測定器（BGM）販売の成長

南北アメリカ市場
・南北アメリカの国別の血糖測定器（BGM）販売量、売上（2018-2023）
・南北アメリカの血糖測定器（BGM）の種類別販売量
・南北アメリカの血糖測定器（BGM）の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の血糖測定器（BGM）販売量、売上（2018-2023）
・アジア太平洋の血糖測定器（BGM）の種類別販売量
・アジア太平洋の血糖測定器（BGM）の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の血糖測定器（BGM）販売量、売上（2018-2023）
・ヨーロッパの血糖測定器（BGM）の種類別販売量
・ヨーロッパの血糖測定器（BGM）の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の血糖測定器（BGM）販売量、売上（2018-2023）
・中東・アフリカの血糖測定器（BGM）の種類別販売量
・中東・アフリカの血糖測定器（BGM）の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・血糖測定器（BGM）の製造コスト構造分析
・血糖測定器（BGM）の製造プロセス分析
・血糖測定器（BGM）の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・血糖測定器（BGM）の主要なグローバル販売業者
・血糖測定器（BGM）の主要なグローバル顧客

地域別の血糖測定器（BGM）市場予測レビュー
・地域別の血糖測定器（BGM）市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・血糖測定器（BGM）の種類別市場規模予測
・血糖測定器（BGM）の用途別市場規模予測

主要企業分析
Becton、 Dickinson and Co.、 Terumo Corporation、 Acon Laboratories Inc.、 Roche Diagnostics Ltd.、 Johnson & Johnson、 ARKRAY Inc.、 Novo Nordisk A/S、 Medtronic、 Abbott Laboratories、 Bayer AG、 Ypsomed AG、 Sanofi
・企業情報
・血糖測定器（BGM）製品
・血糖測定器（BGM）販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Continuous Glucose Monitoring is an advanced way for people living with diabetes to check glucose readings in real-time or monitor glucose readings over a period of time.
LPI (LP Information)’ newest research report, the “Blood Glucose Monitoring (BGM) Industry Forecast” looks at past sales and reviews total world Blood Glucose Monitoring (BGM) sales in 2022, providing a comprehensive analysis by region and market sector of projected Blood Glucose Monitoring (BGM) sales for 2023 through 2029. With Blood Glucose Monitoring (BGM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Glucose Monitoring (BGM) industry.
This Insight Report provides a comprehensive analysis of the global Blood Glucose Monitoring (BGM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Glucose Monitoring (BGM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Glucose Monitoring (BGM) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Glucose Monitoring (BGM) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Glucose Monitoring (BGM).
The global Blood Glucose Monitoring (BGM) market size is projected to grow from US$ 7696.2 million in 2022 to US$ 10640 million in 2029; it is expected to grow at a CAGR of 10640 from 2023 to 2029.
The U.S. market is projected to dominate the strip test segment due to the rise in the patient population, innovation in technology and health care spending while China has the highest number of self-monitoring system users. Asia Pacific and Europe are anticipated to grow over the forecast period owing to increase in some diabetic patients, lifestyle changes, increasing the prevalence of diabetes, and increasing research on diabetes and continuous innovation in technologies and its management. China is expected to witness significant growth for the BRIC diabetes device market followed by other countries such as India, Russia and Brazil.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Glucose Monitoring (BGM) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Blood Glucose Meters
Continuous Glucose Monitoring Devices
Lancets
Blood Glucose Testing Strips
Segmentation by application
Hospital Use
Clinic Use
Household
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Becton
Dickinson and Co.
Terumo Corporation
Acon Laboratories Inc.
Roche Diagnostics Ltd.
Johnson & Johnson
ARKRAY Inc.
Novo Nordisk A/S
Medtronic
Abbott Laboratories
Bayer AG
Ypsomed AG
Sanofi
Key Questions Addressed in this Report
What is the 10-year outlook for the global Blood Glucose Monitoring (BGM) market?
What factors are driving Blood Glucose Monitoring (BGM) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood Glucose Monitoring (BGM) market opportunities vary by end market size?
How does Blood Glucose Monitoring (BGM) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blood Glucose Monitoring (BGM) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Blood Glucose Monitoring (BGM) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Blood Glucose Monitoring (BGM) by Country/Region, 2018, 2022 & 2029
2.2 Blood Glucose Monitoring (BGM) Segment by Type
2.2.1 Blood Glucose Meters
2.2.2 Continuous Glucose Monitoring Devices
2.2.3 Lancets
2.2.4 Blood Glucose Testing Strips
2.3 Blood Glucose Monitoring (BGM) Sales by Type
2.3.1 Global Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2023)
2.3.2 Global Blood Glucose Monitoring (BGM) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Blood Glucose Monitoring (BGM) Sale Price by Type (2018-2023)
2.4 Blood Glucose Monitoring (BGM) Segment by Application
2.4.1 Hospital Use
2.4.2 Clinic Use
2.4.3 Household
2.4.4 Other
2.5 Blood Glucose Monitoring (BGM) Sales by Application
2.5.1 Global Blood Glucose Monitoring (BGM) Sale Market Share by Application (2018-2023)
2.5.2 Global Blood Glucose Monitoring (BGM) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Blood Glucose Monitoring (BGM) Sale Price by Application (2018-2023)
3 Global Blood Glucose Monitoring (BGM) by Company
3.1 Global Blood Glucose Monitoring (BGM) Breakdown Data by Company
3.1.1 Global Blood Glucose Monitoring (BGM) Annual Sales by Company (2018-2023)
3.1.2 Global Blood Glucose Monitoring (BGM) Sales Market Share by Company (2018-2023)
3.2 Global Blood Glucose Monitoring (BGM) Annual Revenue by Company (2018-2023)
3.2.1 Global Blood Glucose Monitoring (BGM) Revenue by Company (2018-2023)
3.2.2 Global Blood Glucose Monitoring (BGM) Revenue Market Share by Company (2018-2023)
3.3 Global Blood Glucose Monitoring (BGM) Sale Price by Company
3.4 Key Manufacturers Blood Glucose Monitoring (BGM) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Glucose Monitoring (BGM) Product Location Distribution
3.4.2 Players Blood Glucose Monitoring (BGM) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Blood Glucose Monitoring (BGM) by Geographic Region
4.1 World Historic Blood Glucose Monitoring (BGM) Market Size by Geographic Region (2018-2023)
4.1.1 Global Blood Glucose Monitoring (BGM) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Blood Glucose Monitoring (BGM) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Blood Glucose Monitoring (BGM) Market Size by Country/Region (2018-2023)
4.2.1 Global Blood Glucose Monitoring (BGM) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Blood Glucose Monitoring (BGM) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Blood Glucose Monitoring (BGM) Sales Growth
4.4 APAC Blood Glucose Monitoring (BGM) Sales Growth
4.5 Europe Blood Glucose Monitoring (BGM) Sales Growth
4.6 Middle East & Africa Blood Glucose Monitoring (BGM) Sales Growth
5 Americas
5.1 Americas Blood Glucose Monitoring (BGM) Sales by Country
5.1.1 Americas Blood Glucose Monitoring (BGM) Sales by Country (2018-2023)
5.1.2 Americas Blood Glucose Monitoring (BGM) Revenue by Country (2018-2023)
5.2 Americas Blood Glucose Monitoring (BGM) Sales by Type
5.3 Americas Blood Glucose Monitoring (BGM) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Glucose Monitoring (BGM) Sales by Region
6.1.1 APAC Blood Glucose Monitoring (BGM) Sales by Region (2018-2023)
6.1.2 APAC Blood Glucose Monitoring (BGM) Revenue by Region (2018-2023)
6.2 APAC Blood Glucose Monitoring (BGM) Sales by Type
6.3 APAC Blood Glucose Monitoring (BGM) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Blood Glucose Monitoring (BGM) by Country
7.1.1 Europe Blood Glucose Monitoring (BGM) Sales by Country (2018-2023)
7.1.2 Europe Blood Glucose Monitoring (BGM) Revenue by Country (2018-2023)
7.2 Europe Blood Glucose Monitoring (BGM) Sales by Type
7.3 Europe Blood Glucose Monitoring (BGM) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blood Glucose Monitoring (BGM) by Country
8.1.1 Middle East & Africa Blood Glucose Monitoring (BGM) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Blood Glucose Monitoring (BGM) Revenue by Country (2018-2023)
8.2 Middle East & Africa Blood Glucose Monitoring (BGM) Sales by Type
8.3 Middle East & Africa Blood Glucose Monitoring (BGM) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Glucose Monitoring (BGM)
10.3 Manufacturing Process Analysis of Blood Glucose Monitoring (BGM)
10.4 Industry Chain Structure of Blood Glucose Monitoring (BGM)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Glucose Monitoring (BGM) Distributors
11.3 Blood Glucose Monitoring (BGM) Customer
12 World Forecast Review for Blood Glucose Monitoring (BGM) by Geographic Region
12.1 Global Blood Glucose Monitoring (BGM) Market Size Forecast by Region
12.1.1 Global Blood Glucose Monitoring (BGM) Forecast by Region (2024-2029)
12.1.2 Global Blood Glucose Monitoring (BGM) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Blood Glucose Monitoring (BGM) Forecast by Type
12.7 Global Blood Glucose Monitoring (BGM) Forecast by Application
13 Key Players Analysis
13.1 Becton
13.1.1 Becton Company Information
13.1.2 Becton Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.1.3 Becton Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Becton Main Business Overview
13.1.5 Becton Latest Developments
13.2 Dickinson and Co.
13.2.1 Dickinson and Co. Company Information
13.2.2 Dickinson and Co. Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.2.3 Dickinson and Co. Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Dickinson and Co. Main Business Overview
13.2.5 Dickinson and Co. Latest Developments
13.3 Terumo Corporation
13.3.1 Terumo Corporation Company Information
13.3.2 Terumo Corporation Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.3.3 Terumo Corporation Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Terumo Corporation Main Business Overview
13.3.5 Terumo Corporation Latest Developments
13.4 Acon Laboratories Inc.
13.4.1 Acon Laboratories Inc. Company Information
13.4.2 Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.4.3 Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Acon Laboratories Inc. Main Business Overview
13.4.5 Acon Laboratories Inc. Latest Developments
13.5 Roche Diagnostics Ltd.
13.5.1 Roche Diagnostics Ltd. Company Information
13.5.2 Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.5.3 Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Roche Diagnostics Ltd. Main Business Overview
13.5.5 Roche Diagnostics Ltd. Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.6.3 Johnson & Johnson Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 ARKRAY Inc.
13.7.1 ARKRAY Inc. Company Information
13.7.2 ARKRAY Inc. Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.7.3 ARKRAY Inc. Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ARKRAY Inc. Main Business Overview
13.7.5 ARKRAY Inc. Latest Developments
13.8 Novo Nordisk A/S
13.8.1 Novo Nordisk A/S Company Information
13.8.2 Novo Nordisk A/S Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.8.3 Novo Nordisk A/S Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novo Nordisk A/S Main Business Overview
13.8.5 Novo Nordisk A/S Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.9.3 Medtronic Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Information
13.10.2 Abbott Laboratories Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.10.3 Abbott Laboratories Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Abbott Laboratories Main Business Overview
13.10.5 Abbott Laboratories Latest Developments
13.11 Bayer AG
13.11.1 Bayer AG Company Information
13.11.2 Bayer AG Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.11.3 Bayer AG Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Bayer AG Main Business Overview
13.11.5 Bayer AG Latest Developments
13.12 Ypsomed AG
13.12.1 Ypsomed AG Company Information
13.12.2 Ypsomed AG Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.12.3 Ypsomed AG Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ypsomed AG Main Business Overview
13.12.5 Ypsomed AG Latest Developments
13.13 Sanofi
13.13.1 Sanofi Company Information
13.13.2 Sanofi Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
13.13.3 Sanofi Blood Glucose Monitoring (BGM) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sanofi Main Business Overview
13.13.5 Sanofi Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Blood Glucose Monitoring (BGM) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Blood Glucose Monitoring (BGM) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Blood Glucose Meters
Table 4. Major Players of Continuous Glucose Monitoring Devices
Table 5. Major Players of Lancets
Table 6. Major Players of Blood Glucose Testing Strips
Table 7. Global Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
Table 8. Global Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2023)
Table 9. Global Blood Glucose Monitoring (BGM) Revenue by Type (2018-2023) & ($ million)
Table 10. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2018-2023)
Table 11. Global Blood Glucose Monitoring (BGM) Sale Price by Type (2018-2023) & (USD/Unit)
Table 12. Global Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
Table 13. Global Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2023)
Table 14. Global Blood Glucose Monitoring (BGM) Revenue by Application (2018-2023)
Table 15. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Application (2018-2023)
Table 16. Global Blood Glucose Monitoring (BGM) Sale Price by Application (2018-2023) & (USD/Unit)
Table 17. Global Blood Glucose Monitoring (BGM) Sales by Company (2018-2023) & (K Units)
Table 18. Global Blood Glucose Monitoring (BGM) Sales Market Share by Company (2018-2023)
Table 19. Global Blood Glucose Monitoring (BGM) Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Company (2018-2023)
Table 21. Global Blood Glucose Monitoring (BGM) Sale Price by Company (2018-2023) & (USD/Unit)
Table 22. Key Manufacturers Blood Glucose Monitoring (BGM) Producing Area Distribution and Sales Area
Table 23. Players Blood Glucose Monitoring (BGM) Products Offered
Table 24. Blood Glucose Monitoring (BGM) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Blood Glucose Monitoring (BGM) Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Blood Glucose Monitoring (BGM) Sales Market Share Geographic Region (2018-2023)
Table 29. Global Blood Glucose Monitoring (BGM) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Blood Glucose Monitoring (BGM) Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Blood Glucose Monitoring (BGM) Sales Market Share by Country/Region (2018-2023)
Table 33. Global Blood Glucose Monitoring (BGM) Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Blood Glucose Monitoring (BGM) Sales by Country (2018-2023) & (K Units)
Table 36. Americas Blood Glucose Monitoring (BGM) Sales Market Share by Country (2018-2023)
Table 37. Americas Blood Glucose Monitoring (BGM) Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Blood Glucose Monitoring (BGM) Revenue Market Share by Country (2018-2023)
Table 39. Americas Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
Table 40. Americas Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
Table 41. APAC Blood Glucose Monitoring (BGM) Sales by Region (2018-2023) & (K Units)
Table 42. APAC Blood Glucose Monitoring (BGM) Sales Market Share by Region (2018-2023)
Table 43. APAC Blood Glucose Monitoring (BGM) Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Blood Glucose Monitoring (BGM) Revenue Market Share by Region (2018-2023)
Table 45. APAC Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
Table 46. APAC Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
Table 47. Europe Blood Glucose Monitoring (BGM) Sales by Country (2018-2023) & (K Units)
Table 48. Europe Blood Glucose Monitoring (BGM) Sales Market Share by Country (2018-2023)
Table 49. Europe Blood Glucose Monitoring (BGM) Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Blood Glucose Monitoring (BGM) Revenue Market Share by Country (2018-2023)
Table 51. Europe Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
Table 52. Europe Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Blood Glucose Monitoring (BGM) Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Blood Glucose Monitoring (BGM) Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Blood Glucose Monitoring (BGM) Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Blood Glucose Monitoring (BGM) Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Blood Glucose Monitoring (BGM)
Table 60. Key Market Challenges & Risks of Blood Glucose Monitoring (BGM)
Table 61. Key Industry Trends of Blood Glucose Monitoring (BGM)
Table 62. Blood Glucose Monitoring (BGM) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Blood Glucose Monitoring (BGM) Distributors List
Table 65. Blood Glucose Monitoring (BGM) Customer List
Table 66. Global Blood Glucose Monitoring (BGM) Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Blood Glucose Monitoring (BGM) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Blood Glucose Monitoring (BGM) Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Blood Glucose Monitoring (BGM) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Blood Glucose Monitoring (BGM) Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Blood Glucose Monitoring (BGM) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Blood Glucose Monitoring (BGM) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Blood Glucose Monitoring (BGM) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Blood Glucose Monitoring (BGM) Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Blood Glucose Monitoring (BGM) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Blood Glucose Monitoring (BGM) Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Blood Glucose Monitoring (BGM) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Blood Glucose Monitoring (BGM) Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Blood Glucose Monitoring (BGM) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Becton Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 81. Becton Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 82. Becton Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Becton Main Business
Table 84. Becton Latest Developments
Table 85. Dickinson and Co. Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 86. Dickinson and Co. Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 87. Dickinson and Co. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Dickinson and Co. Main Business
Table 89. Dickinson and Co. Latest Developments
Table 90. Terumo Corporation Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 91. Terumo Corporation Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 92. Terumo Corporation Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Terumo Corporation Main Business
Table 94. Terumo Corporation Latest Developments
Table 95. Acon Laboratories Inc. Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 96. Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 97. Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Acon Laboratories Inc. Main Business
Table 99. Acon Laboratories Inc. Latest Developments
Table 100. Roche Diagnostics Ltd. Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 101. Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 102. Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Roche Diagnostics Ltd. Main Business
Table 104. Roche Diagnostics Ltd. Latest Developments
Table 105. Johnson & Johnson Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 106. Johnson & Johnson Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 107. Johnson & Johnson Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Johnson & Johnson Main Business
Table 109. Johnson & Johnson Latest Developments
Table 110. ARKRAY Inc. Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 111. ARKRAY Inc. Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 112. ARKRAY Inc. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. ARKRAY Inc. Main Business
Table 114. ARKRAY Inc. Latest Developments
Table 115. Novo Nordisk A/S Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 116. Novo Nordisk A/S Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 117. Novo Nordisk A/S Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Novo Nordisk A/S Main Business
Table 119. Novo Nordisk A/S Latest Developments
Table 120. Medtronic Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 121. Medtronic Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 122. Medtronic Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Medtronic Main Business
Table 124. Medtronic Latest Developments
Table 125. Abbott Laboratories Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 126. Abbott Laboratories Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 127. Abbott Laboratories Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Abbott Laboratories Main Business
Table 129. Abbott Laboratories Latest Developments
Table 130. Bayer AG Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 131. Bayer AG Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 132. Bayer AG Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Bayer AG Main Business
Table 134. Bayer AG Latest Developments
Table 135. Ypsomed AG Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 136. Ypsomed AG Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 137. Ypsomed AG Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Ypsomed AG Main Business
Table 139. Ypsomed AG Latest Developments
Table 140. Sanofi Basic Information, Blood Glucose Monitoring (BGM) Manufacturing Base, Sales Area and Its Competitors
Table 141. Sanofi Blood Glucose Monitoring (BGM) Product Portfolios and Specifications
Table 142. Sanofi Blood Glucose Monitoring (BGM) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Sanofi Main Business
Table 144. Sanofi Latest Developments
List of Figures
Figure 1. Picture of Blood Glucose Monitoring (BGM)
Figure 2. Blood Glucose Monitoring (BGM) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Glucose Monitoring (BGM) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Blood Glucose Monitoring (BGM) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Blood Glucose Monitoring (BGM) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Blood Glucose Meters
Figure 10. Product Picture of Continuous Glucose Monitoring Devices
Figure 11. Product Picture of Lancets
Figure 12. Product Picture of Blood Glucose Testing Strips
Figure 13. Global Blood Glucose Monitoring (BGM) Sales Market Share by Type in 2022
Figure 14. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2018-2023)
Figure 15. Blood Glucose Monitoring (BGM) Consumed in Hospital Use
Figure 16. Global Blood Glucose Monitoring (BGM) Market: Hospital Use (2018-2023) & (K Units)
Figure 17. Blood Glucose Monitoring (BGM) Consumed in Clinic Use
Figure 18. Global Blood Glucose Monitoring (BGM) Market: Clinic Use (2018-2023) & (K Units)
Figure 19. Blood Glucose Monitoring (BGM) Consumed in Household
Figure 20. Global Blood Glucose Monitoring (BGM) Market: Household (2018-2023) & (K Units)
Figure 21. Blood Glucose Monitoring (BGM) Consumed in Other
Figure 22. Global Blood Glucose Monitoring (BGM) Market: Other (2018-2023) & (K Units)
Figure 23. Global Blood Glucose Monitoring (BGM) Sales Market Share by Application (2022)
Figure 24. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Application in 2022
Figure 25. Blood Glucose Monitoring (BGM) Sales Market by Company in 2022 (K Units)
Figure 26. Global Blood Glucose Monitoring (BGM) Sales Market Share by Company in 2022
Figure 27. Blood Glucose Monitoring (BGM) Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Company in 2022
Figure 29. Global Blood Glucose Monitoring (BGM) Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Blood Glucose Monitoring (BGM) Sales 2018-2023 (K Units)
Figure 32. Americas Blood Glucose Monitoring (BGM) Revenue 2018-2023 ($ Millions)
Figure 33. APAC Blood Glucose Monitoring (BGM) Sales 2018-2023 (K Units)
Figure 34. APAC Blood Glucose Monitoring (BGM) Revenue 2018-2023 ($ Millions)
Figure 35. Europe Blood Glucose Monitoring (BGM) Sales 2018-2023 (K Units)
Figure 36. Europe Blood Glucose Monitoring (BGM) Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Blood Glucose Monitoring (BGM) Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Blood Glucose Monitoring (BGM) Revenue 2018-2023 ($ Millions)
Figure 39. Americas Blood Glucose Monitoring (BGM) Sales Market Share by Country in 2022
Figure 40. Americas Blood Glucose Monitoring (BGM) Revenue Market Share by Country in 2022
Figure 41. Americas Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2023)
Figure 42. Americas Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2023)
Figure 43. United States Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Blood Glucose Monitoring (BGM) Sales Market Share by Region in 2022
Figure 48. APAC Blood Glucose Monitoring (BGM) Revenue Market Share by Regions in 2022
Figure 49. APAC Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2023)
Figure 50. APAC Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2023)
Figure 51. China Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Blood Glucose Monitoring (BGM) Sales Market Share by Country in 2022
Figure 59. Europe Blood Glucose Monitoring (BGM) Revenue Market Share by Country in 2022
Figure 60. Europe Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2023)
Figure 61. Europe Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2023)
Figure 62. Germany Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Blood Glucose Monitoring (BGM) Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Blood Glucose Monitoring (BGM) Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2023)
Figure 71. Egypt Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Blood Glucose Monitoring (BGM) Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Blood Glucose Monitoring (BGM) in 2022
Figure 77. Manufacturing Process Analysis of Blood Glucose Monitoring (BGM)
Figure 78. Industry Chain Structure of Blood Glucose Monitoring (BGM)
Figure 79. Channels of Distribution
Figure 80. Global Blood Glucose Monitoring (BGM) Sales Market Forecast by Region (2024-2029)
Figure 81. Global Blood Glucose Monitoring (BGM) Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Blood Glucose Monitoring (BGM) Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Blood Glucose Monitoring (BGM) Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Blood Glucose Monitoring (BGM) Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Blood Glucose Monitoring (BGM) Revenue Market Share Forecast by Application (2024-2029)

※参考情報

血糖測定器（BGM）は、血糖値を測定するための医療機器で、主に糖尿病患者にとって重要な役割を果たしています。血糖の管理は、糖尿病における合併症の予防や改善に直結するため、BGMはその全体的な治療計画の一部として不可欠です。

血糖測定器の定義は、血液中のグルコース濃度を定量的に測定するデバイスであり、一般的には小型でポータブルな形状をしています。使用者が簡単に携帯し、自宅や外出先で手軽に血糖値を測定できる点が大きな特徴です。また、BGMは過去数十年で大きな進化を遂げており、より高精度で使いやすくなっています。

血糖測定器の特徴には、主に測定方式の違い、操作の容易さ、結果の表示方法、そしてデータ管理機能があります。測定方式には、血液中のグルコース濃度を電気的に測定する「電気化学式」や、光を利用して測定する「光学式」などがあります。電気化学式血糖測定器が主流ですが、光学式の技術も進んでおり、身体からの血液を必要としない非侵襲的な測定方法の開発が進んでいます。

操作の容易さについては、最近のデバイスはユーザーフレンドリーな設計がなされており、小さな針で指先から少量の血液を取り、測定を行うことができます。結果は数秒で表示され、多くのモデルでは音声や視覚的にサポートされる機能も備えています。

血糖値の測定結果は、従来は数値として表示されるのみでしたが、最近のBGMではデータ管理機能が強化されており、測定データをスマートフォンやタブレットと連携させることで、トレンド分析や長期的な変化を把握することが可能になっています。このようなデータは、治療計画を見直すための重要な材料になります。

血糖測定器には多くの種類があり、市場にはさまざまなモデルが存在しています。一部のモデルは、持ち運びに便利なコンパクトな設計をしているのに対して、他のモデルはより多機能でデータ管理が優れています。特に、持続血糖モニタリング（Continuous Glucose Monitoring, CGM）と呼ばれる技術は、皮膚の下にセンサーを挿入することで、リアルタイムで血糖値を測定し続けることができます。この技術は日常的な血糖の変動を追跡するのに非常に有効であり、糖尿病管理の新たな道を示しています。

用途については、BGMは主に糖尿病患者による日常的な血糖値管理に使用されますが、医療機関や研究機関でも利用されており、臨床試験や糖尿病の研究においても重要な役割を果たしています。また、最近では予備軍とされる人々や、生活習慣病の予防を目的とした健康管理の一環としても利用されるようになってきています。

関連技術としては、先述のCGMのほか、さまざまな新しいデジタルヘルス技術が誕生しています。これらの技術はBGMデバイスのデータと連携し、より効果的な自己管理をサポートします。例えば、アプリケーションを通じて食事内容や運動量などのデータを統合し、血糖値との相関を分析することで、個々のライフスタイルに合った最適なアドバイスを提供できます。

さらに、遠隔医療技術の進展もBGMに新たな可能性をもたらしています。医療従事者は、患者から送られる血糖データを基に、必要に応じて治療計画を見直したり、個別の指導を行ったりすることが容易になりました。このように、BGMはただの測定器具ではなく、技術の進化とともに医療の質を向上させる重要な要素となっています。

最後に、血糖測定器の選択にあたっては、個人のニーズや生活スタイルを考慮することが重要です。患者は、測定器の使いやすさ、精度、機能性、さらにコストを慎重に比較し、自身に最適な製品を選ぶことが求められます。また、使用方法については医療従事者からの指導を受け、自分に合った血糖管理を行うことが大切です。これにより、BGMの利用を最大限に活用し、健康的な生活を維持することができるでしょう。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 血糖測定器（BGM）のグローバル市場予測2023-2029(Global Blood Glucose Monitoring (BGM) Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • コンパニオンアニマル用血糖モニタリングのグローバル市場予測2023-2029
  • 24時間携帯型自動血圧計（ABPM）のグローバル市場予測2023-2029
  • 血糖自己モニタリング用穿刺装置の世界市場見通し2023年-2029年
  • グルコースオキシダーゼ法血糖テストストリップのグローバル市場予測2023-2029
  • コードフリー血糖測定器のグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆